Automated Nucleic Acid Extraction Devices Market Report 2026

Automated Nucleic Acid Extraction Devices Market Overview

• Automated Nucleic Acid Extraction Devices market size has reached to $6.6 billion in 2025 • Expected to grow to $11.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: The Impact Of Rising Infectious Diseases On The Automated Nucleic Acid Extraction Devices Market • Market Trend: Introduction Of Tech Advanced Workstation For Efficient In-Vitro Diagnostics • North America was the largest region in 2025.

The key promising market opportunities in the automated nucleic acid extraction devices market include: • Fully Automated (Segmentation By Product) → Expected gain of $3539.11 Million • Kits (Segmentation By Type) → Expected gain of $1714.99 Million • Instruments (Segmentation By Type) → Expected gain of $1545.15 Million

What Is Covered Under Automated Nucleic Acid Extraction Devices Market?

Automated nucleic acid extraction devices refer to the equipment used for the major amplification processes such as isolation, purification, and concentration to detect specific pathogens in the molecular diagnostic method. These are used to save time and labor when compared to manual extraction of nucleic acids from the same number of samples. The main types of automated nucleic acid extraction devices are instruments, kits and consumables. Instruments refer to measurement tools used by researchers and practitioners for the analysis and assessment of test and measurement equipment through different variables of research subjects, clients, or patients, which are used in automated nucleic acid extraction devices for diagnosis and experimental research, among other downstream applications. The product types include fully automated and semi-automated that are used by end users including hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies and academic research institutes.

What Is The Automated Nucleic Acid Extraction Devices Market Growth Forecast?

The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, rising investments in genomic research, expansion of personalized medicine testing, growing adoption of point-of-care molecular diagnostics, technological improvements in extraction efficiency. Major trends in the forecast period include increasing adoption of fully automated extraction platforms, rising demand for high-throughput molecular diagnostics, growing use of integrated sample-to-result systems, expansion of automated lab workflows, enhanced focus on contamination-free processing.

What Is The Driver Of The Automated Nucleic Acid Extraction Devices Market?

The increased prevalence of infectious diseases is expected to boost the growth of the automated nucleic acid extraction devices market going forward. An infectious disease is a disorder caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites that can be transmitted, directly or indirectly from one person to another or from animals to humans. The surge in infectious diseases, particularly during global health crises such as pandemics, heightens the need for diagnostic testing, with automated nucleic acid extraction devices playing a pivotal role in sample preparation for molecular diagnostics, facilitating the detection of viruses and bacteria. For instance, in September 2023, according to GOV.UK, a UK-based public sector information site, in the first half of 2023, tuberculosis (TB) cases in England rose by 7% compared to the same period in 2022, with notifications increasing from 2,251 to 2,408. Therefore, the increased prevalence of infectious diseases is driving the growth of the automated nucleic acid extraction devices industry.

How Will The Drivers Impact Growth In The Global Automated Nucleic Acid Extraction Devices Market?

• Increasing Demand for Molecular Diagnostics (Medium) – The increasing demand for molecular diagnostics will become a key driver of growth in the automated nucleic acid extraction devices market by 2030. As molecular tests become more common in detecting infectious diseases, cancer, and genetic conditions, labs require scalable and standardized extraction solutions, fueling market expansion. This demand also encourages innovation in automation technology to meet diverse clinical and research needs. As a result, the increasing demand for molecular diagnostics is anticipated to contributing to a 1.5% annual growth in the market. • Expanding Genomic Research Activities (Medium) – The expanding genomic research activities will emerge as a major factor driving the expansion of the market by 2030. As more laboratories engage in large-scale sequencing, gene editing, and molecular diagnostics, manual extraction methods become impractical due to time and labor constraints. Automated systems enable faster processing of diverse sample types with consistent quality, accelerating research timelines. This growth in genomic research thus directly fuels market adoption and innovation in automated extraction technologies. Consequently, the expanding genomic research activities is projected to contributing to a 1.0% annual growth in the market. • Growing Investments in Biopharmaceutical Manufacturing (Low) – The growing investments in biopharmaceutical manufacturing will serve as a key growth catalyst for the market by 2030. As biopharma companies scale up research and development and production, they increasingly adopt automation to improve speed, standardization, and compliance with regulatory standards. This creates strong market pull for advanced, integrated extraction systems that can support large sample volumes and complex workflows. Therefore, this growing investments in biopharmaceutical manufacturing is projected to supporting to a 0.8% annual growth in the market. • Favorable Government Initiatives (Low) – The favorable government initiatives will become a significant driver contributing to the growth of the market by 2030. Favorable government initiatives, such as increased funding for genomic research, disease surveillance, and precision medicine programs, drive demand for high-throughput and reliable nucleic acid extraction technologies. Public health agencies and research institutions often rely on automated systems to efficiently process large volumes of samples with high accuracy. Subsidies and grants for upgrading laboratory infrastructure also enable wider adoption of advanced automated extraction devices, especially in emerging markets. Additionally, regulatory support for molecular diagnostics encourages the integration of automated extraction into standardized clinical workflows. Consequently, the growth in favorable government initiatives is projected to contributing to a 0.5% annual growth in the market.

How Will The Restraints Impact Growth In The Global Automated Nucleic Acid Extraction Devices Market?

• Increasing Regulatory Scrutiny (Medium) – Increasing Regulatory Scrutiny will restrict the growth of the Automated Nucleic Acid Extraction Devices market during the forecast period. Automated nucleic acid extraction devices used in clinical diagnostics face increasing regulatory scrutiny for accuracy and reliability. Regulatory requirements for validation and certification add to product development time and costs. Regulatory scrutiny can delay product approvals and limit market entry, affecting innovation and market growth. • High Competition (Low) – High Competition will restrict the growth of the Automated Nucleic Acid Extraction Devices market during the forecast period. The automated nucleic acid extraction market faces intense competition among established players and new entrants. Competitive pressures affect pricing, profit margins, and market share distribution. High competition may limit the growth potential for individual players and increase marketing and R&D expenses. • Impact of Trade War and Tariff (Low) – Impact of Trade War and Tariff will restrict the growth of the Automated Nucleic Acid Extraction Devices market during the forecast period. Automated extraction devices rely on imported components, reagents, and specialized materials from global suppliers. Trade tariffs and restrictions can increase costs and affect product availability. Trade barriers may also impact technology transfer and international collaboration in molecular diagnostics.

Key Players In The Global Automated Nucleic Acid Extraction Devices Market

Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.

Global Automated Nucleic Acid Extraction Devices Market Trends and Insights

Major companies operating in the automated nucleic acid extraction devices market are developing innovative products such as automated nucleic acid extraction workstations to meet larger customer bases, more sales, and increase revenue. An automated nucleic acid extraction workstation refers to a specialized and automated system designed for the extraction of nucleic acids, such as DNA and RNA, from biological samples. For instance, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of in-vitro diagnostic products, launched the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 stands out as a distinctive in-vitro diagnostic medical device by seamlessly integrating sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This innovative device is capable of concurrently processing up to 48 samples, resulting in a substantial reduction in the time required for obtaining test results. The SAW-48 streamlines the entire process of sample loading, nucleic acid purification, and PCR setup, enhancing the efficiency of STD and HPV detection. The SAW-48 and the Cell Nucleic Acid Extraction Kit contribute to a comprehensive solution, ensuring a more efficient and streamlined approach to the detection of sexually transmitted diseases and human papillomavirus.

What Are Latest Mergers And Acquisitions In The Automated Nucleic Acid Extraction Devices Market?

In January 2023, ALS Limited, an Australia-based analytical and testing services company, acquired Invitek Molecular GmbH from Nuvisan GmbH for an undisclosed amount. With this acquisition, ALS aims to expand its diagnostic capabilities and services to deliver robust solutions to its clients, utilizing Invitek’s technical reputation and experience to offer a complete one-stop-shop solution. Invitek Molecular GmbH is a Germany-based manufacturing company specialized in automated DNA/RNA extraction and nucleic acid purification solutions.

What Defines the Automated Nucleic Acid Extraction Devices Market?

The automated nucleic acid extraction devices market consists of sales of deoxyribonucleic acid (DNA) extraction kits, ribonucleic acid (RNA) extraction kits and protein extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automated Nucleic Acid Extraction Devices Market Report 2026?

The automated nucleic acid extraction devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automated nucleic acid extraction devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.